Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Botulinum Toxin A on Selective Motor Control in Cerebral Palsy
NCT06583343Phase 4Completed
- Sponsor
- Gaziosmanpaşa Training and Research Hospital
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in cerebral palsy (CP), sponsored by Gaziosmanpaşa Training and Research Hospital. Started Aug 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT06583343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06583343.